The first, known as ligand-dependent, is activated via binding of an antigen or immunoglobulin M. The second is related to a tonic, constant BCR activation dependent on the activity of tyrosine kinase LYN and spleen tyrosine kinase (SYK), which ensure CLL cell survival [35]. The gene discussed is SYK; the disease is B-cell chronic lymphocytic leukemia.